Hussman Strategic Advisors, Inc. / UTH
Hussman Strategic Advisors, Inc.’s United Therapeutics Corp Del Position
Does Hussman Strategic Advisors, Inc. own United Therapeutics Corp Del (UTH)? Not currently — the last reported position was 14.7K shares worth $4M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$4M
Q2 2025
Shares
14.7K
% of Portfolio
+0.97%
Quarters Held
14
position exited
Position History UTH
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 14.7K | $4M | +0.97% |
| Q1 2025 | 12.6K | $4M | +0.94% |
| Q4 2024 | 8.4K | $3M | +0.88% |
| Q3 2024 | 6.3K | $2M | +0.55% |
| Q2 2023 | 9.3K | $2M | +0.38% |
| Q4 2021 | 2.6K | $562,000 | +0.12% |
| Q3 2021 | 3.1K | $572,000 | +0.13% |
| Q2 2021 | 7.2K | $1M | +0.27% |
| Q1 2021 | 10.8K | $2M | +0.37% |
| Q4 2020 | 10.2K | $2M | +0.41% |
| Q3 2020 | 25.5K | $3M | +0.68% |
| Q3 2019 | 10.0K | $798,000 | +0.23% |
| Q2 2019 | 25.0K | $2M | +0.55% |
| Q1 2019 | 25.0K | $3M | +0.72% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hussman Strategic Advisors, Inc.’s full portfolio or all institutional holders of UTH.